Related content

Comparison of two cyclosporine formulations in healthy Middle Eastern volunteers: bioequivalence of the new Sigmasporin Microoral and Sandimmun Neoral

By Najib N.M.   Idkaidek N.   Adel A.   Mohammed B.   Al-Masri S.   Admour I.   Alam S.M.   Dham R.   Qumaruzaman  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 55, Iss. 1, 2003-01 ,pp. : 67-70

Elsevier

Access to resources Recommend Favorite

Comparison of Pharmacokinetics of Cyclosporine A in Cadaveric and Living- Related Renal Transplant Recipients and in an Experimental Rat Model of Renal Failure

By  

Drug Metabolism Letters, Vol. 3, Iss. 3, 2009-08 ,pp. : 152-161

Bentham Science Publishers

Access to resources Recommend Favorite

A non-invasive CYP3A4 biomarker and body mass index predict cyclosporine dosage requirements in Chinese renal transplant recipients

By Cai Ningfang   Li Bifeng   Huang Xiaohong   Xu Kezhen   Feng Huiping   Cheng Zeneng   Zhu Lijun   Zheng Liyun   Luo Xi  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 12, 2015-12 ,pp. : 815-818

Govi-Verlag

Access to resources Recommend Favorite

Medication Noncompliance and its Implications in Transplant Recipients

By Morrissey Paul E.  

Drugs, Vol. 67, Iss. 10, 2007-01 ,pp. : 1463-1481

Adis International

Access to resources Recommend Favorite

Cyclosporin: An Updated Review of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral) in Organ Transplantation

By Dunn C.J.   Wagstaff A.J.   Perry C.M.   Plosker G.L.   Goa K.L.  

Drugs, Vol. 61, Iss. 13, 2001-01 ,pp. : 1957-2016

Adis International

Access to resources Recommend Favorite